COVID-19 Delta Variant Co-Infection Mimicking COVID-19 ARDS
The Delta variant of COVID-19 has been associated with severe disease causing a surge in the second half of 2021. Atypical pathogens can be present in those in particular with severe ARDS and can contribute to excess morbidity and mortality. We must maintain a high level of suspicion for these patho...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
SAGE Publishing,
2022-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_bc90b3cd7dc044d8be5279a2a6e824f2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a James Crosby DO |e author |
| 700 | 1 | 0 | |a Sarah Semon MD |e author |
| 700 | 1 | 0 | |a Subramanya Shyam Ganti MD, MBBS |e author |
| 700 | 1 | 0 | |a Enid Klauber-Choephel MD |e author |
| 700 | 1 | 0 | |a James Abraham MD |e author |
| 245 | 0 | 0 | |a COVID-19 Delta Variant Co-Infection Mimicking COVID-19 ARDS |
| 260 | |b SAGE Publishing, |c 2022-10-01T00:00:00Z. | ||
| 500 | |a 2324-7096 | ||
| 500 | |a 10.1177/23247096221129925 | ||
| 520 | |a The Delta variant of COVID-19 has been associated with severe disease causing a surge in the second half of 2021. Atypical pathogens can be present in those in particular with severe ARDS and can contribute to excess morbidity and mortality. We must maintain a high level of suspicion for these pathogens as this can present an opportunity to dramatically improve the prognosis of a patient with COVID-19 ARDS. However, lend caution to Mycoplasma IgM serology as this can be a false-positive. If suspicion remains high for Mycoplasma pneumoniae infection, sputum polymerase chain reaction (PCR) for M pneumoniae is the gold standard for diagnosis. We present the case of a 42-year-old female with COVID-19 Delta variant presumed ARDS who had co-infection with M pneumoniae confirmed by endotracheal sputum aspirate PCR with rapidly improving oxygenation and extubation within 4 days of effective antibiotic therapy. | ||
| 546 | |a EN | ||
| 690 | |a Medicine (General) | ||
| 690 | |a R5-920 | ||
| 690 | |a Pathology | ||
| 690 | |a RB1-214 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Investigative Medicine High Impact Case Reports, Vol 10 (2022) | |
| 787 | 0 | |n https://doi.org/10.1177/23247096221129925 | |
| 787 | 0 | |n https://doaj.org/toc/2324-7096 | |
| 856 | 4 | 1 | |u https://doaj.org/article/bc90b3cd7dc044d8be5279a2a6e824f2 |z Connect to this object online. |